Optimi Health

Optimi Health Assets per Share

The Total Assets per Share of Optimi Health (OPTI.CN) as of Oct 27, 2026 is 0.16 CAD. In the previous year, Total Assets per Share was 0.15 CAD — a change of 4.55% (higher).

Assets per Share

0.16CAD

YoY

4.55%

Last updated:

Total Assets per Share of Optimi Health is 2025 0.16 CAD. Total Assets per Share of Optimi Health was 2024 0.15 CAD. It decreases by 4.55% higher compared to the previous year.

The Optimi Health Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2020
0.06 CAD
Jan 1, 2021
0.24 CAD
Jan 1, 2022
0.17 CAD
Jan 1, 2023
0.17 CAD
Jan 1, 2024
0.15 CAD
Jan 1, 2025
0.16 CAD
The Optimi Health Assets per Share history
YEARAssets per ShareYoY
0.16CAD+4.55%
0.15CAD-11.77%
0.17CAD-1.94%
0.17CAD-28.32%
0.24CAD+280.26%
0.06CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Optimi Health Stock analysis

What does Optimi Health do? Optimi Health Corp develops, cultivates, extracts, processes, and distributes functional mushrooms and psychedelic substances. The company produces licensed drug and nutraceutical products including natural and synthetically formulated GMP-grade psilocybin, psilocin, MDMA, and other psychedelic substances under Health Canada regulations. Optimi supplies health food distributors, drug developers, and patients through its manufacturing facilities. The firm operates as a supplier of drug and nutraceutical products serving domestic and international health and wellness markets. Optimi Health Corp owns approximately 20,000 technologically advanced manufacturing, cultivation, and analytical facilities. These facilities support the production of functional mushrooms and psychedelic substances for health food distributors, drug developers, and patients. The company focuses on supplying synthetic and natural psychedelics to the international market while adhering to Health Canada's drug manufacturing and formulation standards. The firm's product portfolio includes GMP-grade psilocybin, psilocin, MDMA, and functional mushrooms, targeting health food distributors, drug developers, and patients. Optimi operates as a supplier of drug and nutraceutical products, serving both domestic and international health and wellness markets. Its manufacturing capabilities enable the production of natural and synthetically formulated psychedelic substances under Health Canada's regulatory framework. Optimi Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Optimi Health stock

Total Assets per Share of Optimi Health is 0.16 CAD in 2025.

Total Assets per Share of Optimi Health changed from 0.15 CAD to 0.16 CAD, representing a 4.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Optimi Health since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Optimi Health

All Key Metrics — Optimi Health